14 /100
LOW RISK
Score updated Apr 13, 2026

FATE

Fate Therapeutics, Inc. — Stock Dilution Tracker

Track FATE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track FATE — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
19%
🔄 Reverse Split 30%
• 50-day avg $1.25 approaching $1 threshold
🔁 Convertible Conversion 15%
• Convertible debt present: 13.9% potential dilution
🔔 Track FATE — Get forecast alerts →
💹 Market Data
Market Cap$144.17M
Shares Outstanding116.26M
Float101.62M
Cash$203.66M
Debt$77.85M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 11.3% shares (2025Q4 vs prior)
142 institutional holders · 72.64M shares
#1 Redmile Group, LLC 12.87M shares
#2 BlackRock, Inc. 10.18M shares
#3 VANGUARD GROUP INC 8.97M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest9.86M
Days to Cover6.6
% of Float9.7%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2017
xbrl XBRL CONVERTIBLE Dec 31, 2013
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track FATE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FATE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required